FDA is soliciting feedback on the opportunities and challenges with utilizing AI/ML in the development of drugs, as well as in the development of medical devices intended to be used with drugs.
Comments are due August 9 at the link below.
If you do comment, please consider noting that you are an INFORMS member, and please consider joining and posting to the INFORMS Advocacy and Government Opportunity and Information Community that you have submitted a response.
You may obtain the discussion paper, "Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products: Discussion Paper" at
https://www.fda.gov/science-research/science-and-research-special-topics/artificial-intelligence-and-machine-learning-aiml-drug-development.
Submit comments at this link:
https://www.federalregister.gov/documents/2023/05/11/2023-09985/using-artificial-intelligence-and-machine-learning-in-the-development-of-drug-and-biological
before August 9.
------------------------------
Kara Morgan
Principal
Quant Policy Strategies, LLC
Dublin OH
------------------------------